Lorraine K. Fay - Concepedia

Author

Lorraine K. Fay

Also Known As

Lorraine Fay, Lorraine K. Fay

Publications

322

Citations

H-Index

Concepts

All Affiliations

Lorraine K. Fay is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	308
2	Natural Sciences	3	3	281
3	Biochemistry	3	3	281
4	Education	1	1	14
5	Social Sciences	1	1	14

Lorraine K. Fay

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith, ACS Medicinal Chemistry Letters Pharmaceutical ScienceMolecular PainPharmacotherapyPharmaceutical ChemistryRat Model	2010	196
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryBiochemistryNatural SciencesMedicineBenzothiophene Piperazine	2009	63
Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder Douglas S. Johnson, Chung Sik Choi, Lorraine K. Fay, Bioorganic & Medicinal Chemistry Letters Psychoactive DrugPsychiatryMedicineDrug DiscoveryPsychopharmacology	2011	27
Design, Synthesis, and Biological Activity of Novel Polycyclic Aza-Amide FKBP12 Ligands Raymond A. Hudack, Nancy S. Barta, Chuangxing Guo, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetUnique SeriesOrganic ChemistryOptic Nerve Degeneration	2006	22
Siblings of children with mental retardation: Family characteristics and adjustment Denis J. Lynch, Lorraine K. Fay, Jeanne B. Funk, Journal of Child and Family Studies Child PsychologyDevelopmental DisabilityChild Mental HealthPediatricsEducation	1993	14

Page 1